Chairman of Xiamen Amoytop Biotech (688278.SH) proposed to repurchase company shares with an amount of 100 million to 200 million yuan.

Tebao Biological (688278.SH) announced that the board of directors received a letter from the chairman of the company, Mr. Sun Li, on March 12, 2026, regarding the "Proposal for Xiamen Tebao Biological Engineering Co., Ltd. to repurchase company shares". Mr. Sun suggested that the company use its own funds and self-raised funds to repurchase a portion of the company's issued Renminbi ordinary shares (A shares) through centralized bidding on the Shanghai Stock Exchange system. The total amount of funds to repurchase shares: not less than 100 million yuan (inclusive), and not more than 200 million yuan (inclusive). The repurchase price of shares shall not exceed 85 yuan/share (inclusive). The purpose of repurchasing shares is to use them for implementing employee stock ownership plans and/or equity incentives in the future, or to convert convertible bonds issued by the company into stocks.